Setting the Benchmark for Efficacy & Safety in CAR-T Therapy

12:30 pm - Thursday 17th September 2026

  • Learnings on dual CAR-T design, why targeting CD20xCD22 simultaneously
  • Rationale for NHL indication
  • Present the eti-cel preliminary data